HIGH-DOSE THIOTEPA, CARBOPLATIN AND ETOPOSIDE WITH AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR PATIENTS WITH RECURRENT MEDULLOBLASTOMA

被引:0
|
作者
Gevorgian, Asmik [1 ]
Tolkunova, Polina [1 ]
Iukhta, Tatiana [1 ]
Kazantsev, Ilya [1 ]
Morozova, Elena [1 ]
Andreeva, Tatiana [1 ]
Kozlov, Andrew [1 ]
Safonova, Svetlana [1 ]
Punanov, Yury [1 ]
Zubarovskaya, Ludmila [1 ]
Zheludkova, Olga [2 ]
Afanasyev, Boris [1 ]
机构
[1] Raisa Gorbacheva Mem Inst Pediat Oncol Hematol &, St Petersburg, Russia
[2] Russian Sci Ctr Roentgenoradiol, Moscow, Russia
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MBCL-23
引用
收藏
页码:121 / 121
页数:1
相关论文
共 50 条
  • [31] HIGH-DOSE CARBOPLATIN, ETOPOSIDE AND IFOSFAMIDE AND AUTOLOGOUS STEM-CELL RESCUE IN THE TREATMENT OF NON-HODGKIN LYMPHOMA
    SIEGERT, W
    [J]. PATHOLOGIE BIOLOGIE, 1993, 41 (01): : 104 - 104
  • [32] Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support
    Margolin, K
    Doroshow, JH
    Ahn, C
    Hamasaki, V
    Leong, L
    Morgan, R
    Raschko, J
    Shibata, S
    Somlo, G
    Tetef, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (10) : 2631 - 2637
  • [33] Thiotepa-based high-dose chemotherapy with autologous stem-cell rescue in patients with recurrent or progressive CNS germ cell tumors
    Modak, S
    Gardner, S
    Dunkel, IJ
    Balmaceda, C
    Rosenblum, MK
    Miller, DC
    Halpern, S
    Finlay, JL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (10) : 1934 - 1943
  • [34] Secondary leukemias in refractory germ cell tumor patients undergoing autologous stem-cell transplantation using high-dose etoposide
    Houck, W
    Abonour, R
    Vance, G
    Einhorn, LH
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) : 2155 - 2158
  • [35] Results of tandem high-dose chemotherapy and autologous stem cell transplantation using thiotepa in children with high-risk medulloblastoma
    Daylidite, V.
    Daylidite, Vidmante V.
    Subbotina, Natalia N.
    Dolgopolov, Igor S.
    Babelyan, Stepan S.
    Levashow, Andrey S.
    Mentkevich, Georgy L.
    [J]. BONE MARROW TRANSPLANTATION, 2016, 51 : S513 - S513
  • [36] High-dose busulfan and thiotepa followed by autologous stem cell transplantation (ASCT) in previously irradiated medulloblastoma patients: high toxicity and lack of efficacy
    Valteau-Couanet, D
    Fillipini, B
    Benhamou, E
    Grill, J
    Kalifa, C
    Couanet, D
    Habrand, JL
    Hartmann, O
    [J]. BONE MARROW TRANSPLANTATION, 2005, 36 (11) : 939 - 945
  • [37] High-dose busulfan and thiotepa followed by autologous stem cell transplantation (ASCT) in previously irradiated medulloblastoma patients: high toxicity and lack of efficacy
    D Valteau-Couanet
    B Fillipini
    E Benhamou
    J Grill
    C Kalifa
    D Couanet
    J L Habrand
    O Hartmann
    [J]. Bone Marrow Transplantation, 2005, 36 : 939 - 945
  • [38] Propantheline protects the oral mucosa after high-dose ifosfamide, carboplatin, etoposide and autologous stem cell transplantation
    DJ Oblon
    SR Paul
    MB Oblon
    S Malik
    [J]. Bone Marrow Transplantation, 1997, 20 : 961 - 963
  • [39] Propantheline protects the oral mucosa after high-dose ifosfamide, carboplatin, etoposide and autologous stem cell transplantation
    Oblon, DJ
    Paul, SR
    Oblon, MB
    Malik, S
    [J]. BONE MARROW TRANSPLANTATION, 1997, 20 (11) : 961 - 963
  • [40] High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation
    Demirer, T
    Ayli, M
    Ilhan, O
    Koc, H
    Dagli, M
    Arat, M
    Fen, T
    Dincer, S
    Ozet, G
    Akan, H
    Uysal, A
    [J]. BONE MARROW TRANSPLANTATION, 2003, 31 : S195 - S196